Mike Lucero

TOMA Biosciences is a genomics company that provides physicians with information to optimize treatment for cancer patients. TOMA’s proprietary sequencing solution turns the latest next=generation sequencing (NGS) technology into a powerful digital tool to detect the most clinically meaningful changes in a patient’s tumor DNA. Physicians use thisimportant data to optimize treatment for their patients.TOMA technology enables laboratories to uncover the DNA alterations in cancer cells to provide meaningful data for researchers and clinicians seeking the optimal treatment options for their patients. The company is a commercial-stage private venture-backed company headquartered in Foster City, California.